Ecraid publishes first annual report

In early 2022, after years in the making, Ecraid became a reality. The legal establishment of the foundation marked the start of building the enterprise infrastructure according to the transition roadmap described in the EU-funded Ecraid Business Plan (June 2021). This ambitious effort was backed by the European Union through funding from the Horizon 2020 research and innovation programme allocated for the ECRAID-Base project. Today, Ecraid works with both public and private partners to efficiently generate rigorous evidence to improve the diagnosis, prevention, and treatment of infections, and to better respond to infectious disease threats. 

2022 annual report  

Ecraid’s first annual report offers a comprehensive overview of the foundation’s inaugural year. In it, the Management Board reports on the successful delivery of Ecraid, including building a team and culture, implementing a governance infrastructure, and setting up a headquarters. Ecraid’s focus on collaboration and connected autonomy is emphasised as the principle underpinning each of these efforts.  

Another focus is the integration and expansion of the clinical research networks created under the very fruitful projects COMBACTE and PREPARE. This pan-European clinical research infrastructure is at the heart of Ecraid’s operations and an important part of the services we offer to our partners. 

Finally, the report zooms in on the progress made in key parts of the organisation, such as Business Development, the CLIN-Net hospital network, and our ongoing studies. A timeline visualises some of our 2022 highlights, such as the appointment of key persons and important events.